Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has provided an announcement.
Fusen Pharmaceutical Company Limited has announced the composition of its board of directors and their respective roles, highlighting the leadership structure within the company. The announcement details the membership of three board committees, which are crucial for the company’s governance and operational oversight, potentially impacting its strategic direction and stakeholder engagement.
The most recent analyst rating on (HK:1652) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Fusen Pharmaceutical Co., Ltd. stock, see the HK:1652 Stock Forecast page.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 2,177,365
Technical Sentiment Signal: Buy
Current Market Cap: HK$514.7M
Find detailed analytics on 1652 stock on TipRanks’ Stock Analysis page.